Compare PL & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PL | ALKS |
|---|---|---|
| Founded | 2010 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7B | 8.7B |
| IPO Year | 2021 | 2012 |
| Metric | PL | ALKS |
|---|---|---|
| Price | $24.59 | $49.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 14 |
| Target Price | $27.64 | ★ $43.43 |
| AVG Volume (30 Days) | ★ 6.6M | 1.7M |
| Earning Date | 06-03-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | N/A |
| Revenue | $307,727,000.00 | ★ $1,475,899,000.00 |
| Revenue This Year | $42.29 | $24.26 |
| Revenue Next Year | $30.22 | $4.47 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 25.94 | N/A |
| 52 Week Low | $6.10 | $25.17 |
| 52 Week High | $51.72 | $55.67 |
| Indicator | PL | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 51.27 | 45.88 |
| Support Level | $23.66 | $47.66 |
| Resistance Level | $27.57 | $50.85 |
| Average True Range (ATR) | 1.33 | 1.97 |
| MACD | 0.77 | -0.24 |
| Stochastic Oscillator | 83.83 | 29.28 |
Planet Labs PBC is an Earth-imaging company. It uses space to help life on Earth by imaging the world every day and making change visible, accessible, and actionable. Its platform includes imagery, insights, and machine learning that empower companies, governments, and communities around the world to make timely decisions about the evolving world. Its solutions are Broad Area Management. Its products are Planet Monitoring, Planet Tasking, Planet Analytic Feeds, Planetary Variables, Planet Basemaps, Planet Insights, and Platform Pricing. The group provides solutions to the Agriculture Science Program, Energy & Infrastructure, Forestry & Land Use, Mapping, Sustainability, Maritime, Civil Government, U.S. State and Local, Europe, Planet Federal, Defense & Intelligence, and Armed Services.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.